Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 1;79(4):445-452.
doi: 10.1097/QAI.0000000000001839.

Awareness, Willingness, and PrEP Eligibility Among Transgender Women in Rio de Janeiro, Brazil

Emilia M Jalil  1 , Beatriz Grinsztejn  1 , Luciane Velasque  2 , Alessandra Ramos Makkeda  3 , Paula M Luz  1 , Ronaldo I Moreira  1 , Luciana Kamel  1 , Nilo M Fernandes  1 , Ana Cristina G Ferreira  1 , Brenda Hoagland  1 , Sandra Wagner  1 , Albert Liu  4 , Willi McFarland  5 , Susan Buchbinder  4   5 , Valdilea G Veloso  1 , Erin Wilson  4 ; for Transcender Study Team
Affiliations

Awareness, Willingness, and PrEP Eligibility Among Transgender Women in Rio de Janeiro, Brazil

Emilia M Jalil et al. J Acquir Immune Defic Syndr. .

Abstract

Background: HIV epidemics disproportionately affect transwomen worldwide. Trans-specific guidance, outreach, and interventions to increase pre-exposure prophylaxis (PrEP) use among transwomen are scarce.

Setting: Rio de Janeiro, Brazil.

Methods: We measured awareness and willingness to use PrEP and examined factors associated with those outcomes among transwomen in Rio de Janeiro and estimated how many transwomen would be eligible for PrEP. Data originate from Transcender study, a respondent-driven sampling survey conducted from August 2015 to January 2016. We performed regression models for PrEP awareness and willingness.

Results: One hundred thirty-one (38.0%) of 345 participants had heard of PrEP. Among transwomen who self-reported as HIV-negative, 162 (76.4%, N = 212 with available data) reported willingness to use it and 163 (66.8%, N = 244) met PrEP behavioral eligibility criteria. Transwomen with health access in the previous 6 months who reported HIV-infected sexual partner and with 8+ years of schooling had increased odds of PrEP awareness. Lower PrEP awareness was associated with condomless anal intercourse and newly diagnosed HIV infection. Younger age and perceiving themselves at risk of HIV infection increased the odds of PrEP willingness. Lower odds of PrEP willingness were associated with concerns about long-term effects of PrEP and with difficulties in getting access to health care due to transphobia.

Conclusion: Combination of low awareness, high willingness, and substantial PrEP eligibility corroborates transwomen as a key population for HIV prevention. PrEP is a promising and empowering strategy for HIV prevention among transwomen, but trans-specific recommendations are needed to effectively implement PrEP in this population.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest:

We declare that we have no conflicts of interest.

Figures

Figure 1
Figure 1
The majority of transwomen preferred intramuscular (63, 38.7%) or oral (57, 35.0%) PrEP.
See this image and copyright information in PMC

References

    1. Baral SD, Poteat T, Strömdahl S, et al. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):214–22. - PubMed
    1. Grinsztejn B, Jalil EM, Monteiro L, et al. Unveiling of HIV dynamics among transgender women: a respondent-driven sampling study in Rio de Janeiro, Brazil. Lancet HIV. 2017;4(4):e169–76. - PMC - PubMed
    1. Grant RM, Anderson PL, McMahan V, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14(9):820–9. - PMC - PubMed
    1. Deutsch MB, Glidden DV, Sevelius J, et al. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV. 2015;2(12):e512–9. - PMC - PubMed
    1. Wilson EC, Jalil E, Siqueira BH, et al. PrEP adherence among trans women in Brazil—access needed for this key population. Lancet HIV. 2016;3(5):e200. - PubMed

Publication types